Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

SELL
$1.5 - $3.41 $43,305 - $98,446
-28,870 Reduced 85.41%
4,930 $12,000
Q4 2023

Feb 14, 2024

BUY
$1.82 - $3.16 $45,682 - $79,316
25,100 Added 288.51%
33,800 $81,000
Q3 2023

Nov 07, 2023

BUY
$3.17 - $7.91 $18,924 - $47,222
5,970 Added 218.68%
8,700 $29,000
Q2 2023

Aug 08, 2023

SELL
$7.35 - $13.21 $138,180 - $248,348
-18,800 Reduced 87.32%
2,730 $20,000
Q1 2023

May 12, 2023

BUY
$7.79 - $16.29 $122,536 - $256,241
15,730 Added 271.21%
21,530 $223,000
Q4 2022

Feb 13, 2023

BUY
$11.0 - $21.45 $63,800 - $124,410
5,800 New
5,800 $68,000
Q2 2022

Aug 09, 2022

BUY
$27.42 - $43.63 $158,048 - $251,483
5,764 Added 201.19%
8,629 $267,000
Q1 2022

May 16, 2022

BUY
$36.48 - $52.22 $104,515 - $149,610
2,865 New
2,865 $117,000
Q4 2021

Feb 11, 2022

SELL
$33.11 - $55.01 $69,862 - $116,071
-2,110 Closed
0 $0
Q3 2021

Nov 09, 2021

BUY
$50.07 - $66.05 $105,647 - $139,365
2,110 New
2,110 $105,000
Q1 2021

May 14, 2021

SELL
$86.23 - $125.19 $64,586 - $93,767
-749 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$79.17 - $111.47 $49,006 - $68,999
-619 Reduced 45.25%
749 $67,000
Q3 2020

Nov 16, 2020

BUY
$81.91 - $134.94 $112,052 - $184,597
1,368 New
1,368 $141,000
Q4 2019

Feb 10, 2020

SELL
$51.21 - $59.06 $66,573 - $76,778
-1,300 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$40.6 - $57.2 $52,780 - $74,360
1,300 New
1,300 $67,000
Q3 2018

Nov 13, 2018

SELL
$52.05 - $66.51 $56,214 - $71,830
-1,080 Closed
0 $0
Q2 2018

Aug 13, 2018

BUY
$48.33 - $55.64 $52,196 - $60,091
1,080 New
1,080 $54,000
Q4 2017

Feb 12, 2018

SELL
$37.77 - $47.75 $25,645 - $32,422
-679 Closed
0 $0
Q3 2017

Nov 07, 2017

BUY
$34.14 - $40.45 $23,181 - $27,465
679
679 $27,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $420M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.